PubRank

J G Jonasson

Author PubWeight™ 39.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996 4.38
2 Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 1997 2.28
3 Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999 1.71
4 The accuracy of death certificates. Implications for health statistics. Virchows Arch A Pathol Anat Histopathol 1991 1.28
5 Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 1998 1.28
6 Linkage to BRCA2 region in hereditary male breast cancer. Lancet 1995 1.21
7 BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res 1998 1.20
8 Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005 1.04
9 Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 1999 1.04
10 High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer 2002 1.00
11 Primary cytomegalovirus infection and gastric ulcers in normal host. Dig Dis Sci 1991 0.99
12 Second primary malignancies in patients with male breast cancer. Br J Cancer 2005 0.96
13 pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited. Int J Cancer 2014 0.94
14 Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 2001 0.94
15 Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Anticancer Res 1997 0.94
16 The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequences. Int J Oncol 2000 0.94
17 Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables. Anticancer Res 1999 0.93
18 Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol 1989 0.92
19 Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 1998 0.90
20 p53 abnormality and chromosomal instability in the same breast tumor cells. Cancer Genet Cytogenet 2000 0.87
21 TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material. Br J Cancer 1996 0.86
22 Tubal metaplasia: a cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix. Diagn Cytopathol 1993 0.86
23 Risks of second primary cancer among patients with major histological types of lung cancers in both men and women. Br J Cancer 2010 0.85
24 CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Br J Cancer 2003 0.85
25 Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis. APMIS 1997 0.85
26 Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Scand J Urol Nephrol 2006 0.84
27 Brushing cytology of the upper gastrointestinal tract. Obsolete or not? Acta Cytol 1991 0.84
28 Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int J Cancer 1995 0.83
29 Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival. Cancer Detect Prev 2001 0.83
30 High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. Cancer Res 1998 0.82
31 Genotype-phenotype interactions in Wilson's disease: insight from an Icelandic mutation. Eur J Gastroenterol Hepatol 2001 0.82
32 P53 mutations analysis in benign and malignant breast lesions: using needle rinses from fine-needle aspirations. Diagn Cytopathol 2000 0.80
33 Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study. Aliment Pharmacol Ther 2013 0.79
34 Cellular DNA pattern, S-phase frequency and survival in papillary thyroid cancer. Acta Oncol 1988 0.79
35 Thyroid cancer in Iceland 1955-1984. Acta Endocrinol (Copenh) 1988 0.79
36 The frequency of advanced adenoma in consulting patients: a nationwide survey in Iceland (2003-2006). Colorectal Dis 2012 0.79
37 Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Eur J Cancer 2008 0.78
38 Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer. Eur J Cancer 2000 0.78
39 [Flow cytometric analysis of human malignancies.]. Laeknabladid 1996 0.75
40 [Thyroid cancer in Iceland. Epidemiology and prognostic factors with special emphasis on the results of nuclear DNA-analysis]. Laeknabladid 1994 0.75
41 Tumours in Iceland. 17. Malignant tumours of the oesophagus. Histological classification and epidemiological considerations. APMIS 1992 0.75
42 [DNA flow cytometry is a useful prognostic guide in the treatment of breast cancer.]. Laeknabladid 1996 0.75
43 Cutaneous melanoma in Iceland: changing Breslow's tumour thickness. J Eur Acad Dermatol Venereol 2014 0.75